Is carboplatin as effective as radiotherapy for the adjuvant treatment of stage I seminoma?
Carsten Bokemeyer
Correspondence Department of Internal Medicine II, University Medical Center, Eppendorf, Martinistra
e 52, Hamburg 20246, Germany
Email c.bokemeyer@uke.uni-hamburg.de
This article has no abstract so we have provided the first paragraph of the full text.
The article by Oliver et al. contributes to our understanding of the management of stage I seminoma, and is based on the hypothesis that, since cure rates of almost 100% are achievable in this patient group, clinical decisions should be based on the availability of different treatment modalities, patients' preferences, and treatment-related toxicity.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.